These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26728026)

  • 1. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
    Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
    Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.
    Sandulache VC; Chen Y; Skinner HD; Lu T; Feng L; Court LE; Myers JN; Meyn RE; Fuller CD; Bankson JA; Lai SY
    Mol Cancer Ther; 2015 Dec; 14(12):2901-8. PubMed ID: 26376962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma.
    Freudlsperger C; Horn D; Weißfuß S; Weichert W; Weber KJ; Saure D; Sharma S; Dyckhoff G; Grabe N; Plinkert P; Hoffmann J; Freier K; Hess J
    Int J Cancer; 2015 Jun; 136(12):2775-85. PubMed ID: 25388642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
    Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
    PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
    Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
    Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
    Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
    Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
    Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of neck treatment in patients with head and neck squamous cell carcinoma.
    Buck G; Huguenin P; Stoeckli SJ
    Head Neck; 2008 Jan; 30(1):50-7. PubMed ID: 17636542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.
    Rabassa ME; Pereyra A; Pereyra L; Segal-Eiras A; Abba MC; Croce MV
    Pathol Oncol Res; 2018 Jul; 24(3):525-531. PubMed ID: 28681122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
    Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
    PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice.
    Quennet V; Yaromina A; Zips D; Rosner A; Walenta S; Baumann M; Mueller-Klieser W
    Radiother Oncol; 2006 Nov; 81(2):130-5. PubMed ID: 16973228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic interrogation as a tool to optimize chemotherapeutic regimens.
    Sandulache VC; Chen Y; Feng L; William WN; Skinner HD; Myers JN; Meyn RE; Li J; Mijiti A; Bankson JA; Fuller CD; Konopleva MY; Lai SY
    Oncotarget; 2017 Mar; 8(11):18154-18165. PubMed ID: 28184025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer.
    Brizel DM; Schroeder T; Scher RL; Walenta S; Clough RW; Dewhirst MW; Mueller-Klieser W
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):349-53. PubMed ID: 11567808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of leucine‑rich‑α‑2‑glycoprotein 1 expression is associated with the tumorigenesis of head and neck squamous cell carcinoma.
    Wang Y; Chen C; Hua Q; Wang L; Li F; Li M; Mei Z; Zhou T; Xiao B; Tao Z
    Oncol Rep; 2017 Mar; 37(3):1503-1510. PubMed ID: 28098902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.